コネチカット州における膵臓がんの臨床試験
コネチカット州内の拠点で、膵臓がんに関する25件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Yale University, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07621718A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, New Have
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Hartford Healthcare, Hartford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Hartford Healthcare, Hartford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
- Yale University Cancer Center LAO, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07619521Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Yale Cancer Center, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07349537Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- 他14件
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Danbury Hospital, Danbury
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- 他13件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328Pancreatic Cancer Early Detection Consortium
- Yale University, New Haven
被験者募集中観察研究健康なボランティア歓迎
18歳〜90歳 · 全性別 · 2026/07/22更新 · NCT04970056Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Yale University, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT05053971Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Smilow Cancer Hospital (Yale University), New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Stamford Hospital/Bennett Cancer Center, Stamford
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
- Nuvance Health, Norwalk
被験者募集中観察研究
50歳〜90歳 · 全性別 · 2026/04/13更新 · NCT03250078The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
- Nuvance Health, Norwalk
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/13更新 · NCT04406831A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
- Yale University, New Haven
- Nuvance Health, Norwalk
被験者募集中観察研究健康なボランティア歓迎
50歳以上 · 全性別 · 2026/04/13更新 · NCT03937453A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Hartford Hospital (site 210), Hartford
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774The Cancer of the Pancreas Screening-5 CAPS5)Study
- Yale University, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/09更新 · NCT02000089Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
- Yale School of Medicine, New Haven
被験者募集中観察研究
18歳以上 · 全性別 · 2025/08/22更新 · NCT03492151Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Yale Cancer Center, New Haven
被験者募集中第2/3相
18歳以上 · 全性別 · 2024/11/06更新 · NCT05254171ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。